Christe W |
Neurological disorders in liver and kidney transplant recipients. |
1994 |
Transplant. Proc. |
pmid:7527953
|
Bersztel A et al. |
Deoxyspergualin is synergistic with cyclosporin A, but not with FK506 in a rat heart allograft transplantation model. |
1995 |
Transplant. Proc. |
pmid:8540095
|
Starzl TE |
FK 506 versus cyclosporine. |
1993 |
Transplant. Proc. |
pmid:7679820
|
Fukuzaki T et al. |
Nonvascularized islet xenograft rejection in a mouse-to-rat combination where the vascularized heart is rapidly rejected. |
1994 |
Transplant. Proc. |
pmid:7513472
|
Garcia CD et al. |
Renal transplantation in children less than six years old. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750527
|
Risaliti A et al. |
Cardiovascular and metabolic complications after liver transplantation: Neoral- versus tacrolimus-based immunosuppression. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750569
|
|
First International Congress on FK 506. August 21-24, 1991, Pittsburgh, PA. |
1991 |
Transplant. Proc. |
pmid:1721253
|
Smoter P et al. |
Risk factors of acute renal failure after orthotopic liver transplantation: single-center experience. |
2014 |
Transplant. Proc. |
pmid:25380918
|
Goto T et al. |
FK 506: historical perspectives. |
1991 |
Transplant. Proc. |
pmid:1721254
|
Mendez R |
FK 506 and mycophenolate mofetil in renal transplant recipients: six-month results of a multicenter, randomized dose ranging trial. FK 506 MMF Dose-Ranging Kidney Transplant Study Group. |
1998 |
Transplant. Proc. |
pmid:9636522
|
Yuan QS et al. |
Rescue therapy with tacrolimus in renal graft patients with cyclosporine A-induced hepatotoxicity: a preliminary study. |
2000 |
Transplant. Proc. |
pmid:11119896
|
Vanrenterghem Y et al. |
Co-administration of tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636523
|
Tanabe K et al. |
Japanese single-center experience of kidney transplantation under tacrolimus immunosuppression. |
2000 |
Transplant. Proc. |
pmid:11119897
|
Kahl A et al. |
First results with a quadruple therapy regimen including tacrolimus and mycophenolate mofetil in patients after combined pancreas and kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9532149
|
Bruce DS et al. |
Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9532150
|
Gutiérrez Sánchez MJ et al. |
Optimization of immunosuppression by switching from azathioprine to enteric-coated mycophenolate sodium in stable kidney transplant patients. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715907
|
Rafecas A et al. |
Immunosuppression with calcineurin inhibitors and polyclonal antibodies in liver transplantation. |
2002 |
Transplant. Proc. |
pmid:11959209
|
Aptaramanov B et al. |
A comparison of mycophenolate mofetil with mycophenolate sodium in renal transplant recipients on tacrolimus-based treatment. |
2011 |
Transplant. Proc. |
pmid:21486609
|
Ma A et al. |
Immunological evaluation of combination therapy with tacrolimus and sirolimus on long-term allograft survival in nonhuman primates. |
2005 Jan-Feb |
Transplant. Proc. |
pmid:15808578
|
Fung JJ et al. |
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. |
1990 |
Transplant. Proc. |
pmid:1689901
|
McCauley J et al. |
FK 506 in the management of nephrotic syndrome after renal transplantation. |
1993 |
Transplant. Proc. |
pmid:7680154
|
Farghali H et al. |
FK 506 modulates D-galactosamine-induced hepatitis in rats. |
1991 |
Transplant. Proc. |
pmid:1721285
|
Andrews WS et al. |
Comparison of cyclosporine- vs tacrolimus-based immunosuppression in pediatric liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623452
|
Cantarovich M et al. |
Optimal time points for the prediction of the area-under-the-curve in liver transplant patients receiving tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9636592
|
Hachida M et al. |
Combined use of deoxyspergualin and FK 506 for temporary circulatory assist. |
1999 |
Transplant. Proc. |
pmid:10455968
|
Harihara Y et al. |
Correlation between graft size and necessary tacrolimus dose after living-related liver transplantation. |
2000 |
Transplant. Proc. |
pmid:11120116
|
van Hooff JP et al. |
Tacrolimus and glucose metabolism. |
1999 |
Transplant. Proc. |
pmid:10576044
|
Torio A et al. |
Effect of CYP3A51/3 polymorphism on blood pressure in renal transplant recipients. |
2012 |
Transplant. Proc. |
pmid:23146466
|
Yoshimura N et al. |
Combination therapy of tacrolimus (FK506) with azathioprine and steroids in renal transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9474949
|
Serrano M et al. |
Clinical value of a single determination of intracellular ATP levels in stimulated CD4+ T lymphocytes in pediatric patients with stable liver transplantation. |
2012 |
Transplant. Proc. |
pmid:23146475
|
Kim SJ et al. |
Randomized trial of tacrolimus versus cyclosporine in steroid withdrawal in living donor renal transplant recipients. |
2004 |
Transplant. Proc. |
pmid:15518759
|
Valdivia LA et al. |
Complement and target cells belong to the same species after liver xenografting: protection from hyperacute rejection. |
1994 |
Transplant. Proc. |
pmid:7518123
|
Hayashi S et al. |
Synergistic effect of donor pretreatment using FK 506 in hamster-to-rat cardiac xenotransplantation. |
1994 |
Transplant. Proc. |
pmid:7518126
|
Laftavi MR et al. |
African American renal transplant recipients (RTR) require higher tacrolimus doses to achieve target levels compared to white RTR: does clotrimazole help? |
2013 |
Transplant. Proc. |
pmid:24314941
|
Woodle ES et al. |
Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection. |
1993 |
Transplant. Proc. |
pmid:7682358
|
Senninger N et al. |
Glucose metabolism following liver transplantation and immunosuppression with cyclosporine A or FK 506. |
1995 |
Transplant. Proc. |
pmid:7533364
|
Yagihashi A et al. |
The effect of FK 506 on peripheral blood T-lymphocyte subsets in orthotopic liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721318
|
Ziolkowski J et al. |
Effect of immunosuppressive regimen on acute rejection and liver graft function. |
2003 |
Transplant. Proc. |
pmid:14529915
|
Kato T et al. |
FK506 may suppress liver injury during the early period following living-related liver transplantation. |
2003 |
Transplant. Proc. |
pmid:12591316
|
Bahra M et al. |
Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss. |
2005 |
Transplant. Proc. |
pmid:15919436
|
Kapturczak MH et al. |
Pharmacology of calcineurin antagonists. |
2004 |
Transplant. Proc. |
pmid:15041303
|
Yang SS et al. |
A single center, open-label, randomized pilot study to evaluate the safety and efficacy of tacrolimus modified release, Advagraf, versus tacrolimus twice daily, Prograf, in stable renal recipients (single). |
2015 |
Transplant. Proc. |
pmid:25891697
|
Ã…berg F et al. |
Asymptomatic De Novo Inflammatory Bowel Disease Late After Liver Transplantation for Primary Sclerosing Cholangitis: A Case Report. |
2015 |
Transplant. Proc. |
pmid:26680092
|
Hranjec T et al. |
Benign transient hyperphosphatasemia associated with Epstein-Barr virus enteritis in a pediatric liver transplant patient: a case report. |
2008 |
Transplant. Proc. |
pmid:18589195
|
Varo E et al. |
Alternative immunosuppression for acute renal failure in liver transplantation: role of ultra-low dose tacrolimus and basiliximab. |
2002 |
Transplant. Proc. |
pmid:12176471
|
Saito S et al. |
The pattern of rejection and susceptibility to different kinds of immunosuppression after combined liver, duodenum, and pancreas transplantation in swine--immunosuppressive drugs versus ex vivo immunomodulation of the allograft. |
1995 |
Transplant. Proc. |
pmid:7533420
|
Braun F et al. |
How to handle mycophenolate mofetil in combination with tacrolimus? |
1998 |
Transplant. Proc. |
pmid:9865309
|
Morel P et al. |
Liver retransplantation in adults: overall results and determinant factors affecting the outcome. |
1991 |
Transplant. Proc. |
pmid:1721349
|
Zegarska J et al. |
Tacrolimus Metabolite M-III May Have Nephrotoxic and Myelotoxic Effects and Increase the Incidence of Infections in Kidney Transplant Recipients. |
2016 |
Transplant. Proc. |
pmid:27496443
|
Yuan-Xin L et al. |
Preliminary experience with alemtuzumab induction therapy combined with maintenance low-dose tacrolimus monotherapy in small-bowel transplantation in China. |
2010 Jan-Feb |
Transplant. Proc. |
pmid:20172275
|
Chiereghin A et al. |
Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients. |
2010 Jan-Feb |
Transplant. Proc. |
pmid:20172283
|
Colak T et al. |
Effect of conversion from cyclosporine to tacrolimus on lipid profiles in renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12270321
|
Woodside KJ et al. |
Conversion from cyclosporine to tacrolimus results in improved creatinine but does not alter lipid profile. |
2005 |
Transplant. Proc. |
pmid:15919491
|
Nanni G et al. |
Lack of correlation between serum levels of mycophenolate mofetil and kidney transplant outcome in tacrolimus-based immunosupression. |
2002 |
Transplant. Proc. |
pmid:12270323
|
Chmiel B et al. |
Rheological properties of red blood cells in kidney transplant recipients: the role of lipid profile and type of immunosuppresion. |
2005 |
Transplant. Proc. |
pmid:15919493
|
Sánchez-Pérez B et al. |
Influence of immunosuppression and effect of hepatitis C virus on new onset of diabetes mellitus in liver transplant recipients. |
2008 |
Transplant. Proc. |
pmid:19010171
|
Ye Q et al. |
Persistence of donor cells and incidence of graft-versus-host disease after simultaneous small bowel and bone marrow transplantation. |
1996 |
Transplant. Proc. |
pmid:8907895
|
Waller JR et al. |
Primary immunosuppression with tacrolimus is associated with a reduction in renal allograft fibrosis compared with neoral therapy. |
2002 |
Transplant. Proc. |
pmid:12176496
|
Walgenbach KJ et al. |
Increased presence of mast cells and interleukin-4 during chronic rejection of rat intestinal allografts. |
1996 |
Transplant. Proc. |
pmid:8907896
|
Miyagi M et al. |
Comparison of the therapeutic effects between CsA and FK506 on chronic renal allograft injury and TGF-beta expression. |
2002 |
Transplant. Proc. |
pmid:12176497
|
Malaise J et al. |
Immunosuppressive drugs after simultaneous pancreas-kidney transplantation. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182827
|
Zmonarski SC et al. |
Lowering of Messenger Ribonucleic Acid Toll-Like Receptors 2-4,9 in Peripheral Blood Mononuclear Cells in Kidney Allograft Recipients, Relationships With Immunosuppressive Treatment, and Delayed Graft Function Occurrence. |
2016 |
Transplant. Proc. |
pmid:27496439
|
Oishi M et al. |
Successful swine small bowel transplantation using FK506: effect on endotoxin translocation. |
1994 |
Transplant. Proc. |
pmid:7520629
|
Moutabarrik A et al. |
FK 506 mechanism of nephrotoxicity: stimulatory effect on endothelin secretion by cultured kidney cells and tubular cell toxicity in vitro. |
1991 |
Transplant. Proc. |
pmid:1721382
|
Takeda M et al. |
Immunologic factors contributing to acute rejection in lungs xenotransplanted between primates. |
1998 |
Transplant. Proc. |
pmid:9838670
|
Goller AL et al. |
Loss of serum bicarbonate after discordant liver xenotransplantation. |
2000 |
Transplant. Proc. |
pmid:10936383
|
Murase N et al. |
Immunomodulation of intestinal transplant with allograft irradiation and simultaneous donor bone marrow infusion. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083238
|
Scott-Douglas N et al. |
Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy. |
1996 |
Transplant. Proc. |
pmid:8962226
|
Boots JM et al. |
Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study. |
2002 |
Transplant. Proc. |
pmid:12176542
|
Cho JH et al. |
Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients. |
2012 |
Transplant. Proc. |
pmid:22310591
|
Ji SM et al. |
Conversion from cyclosporine to tacrolimus for chronic allograft nephropathy. |
2007 |
Transplant. Proc. |
pmid:17580148
|
Opelz G |
New immunosuppressants and HLA matching. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266911
|
Jiang H et al. |
IL-10: a tacrolimus-specific cytotoxic mediator in ongoing allograft rejection. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266931
|
Wang X et al. |
Intraportal FK 506 improves intrahepatic islet allograft survival. |
1991 |
Transplant. Proc. |
pmid:1721412
|
Nishimura Y et al. |
Whole organ vascularized thymus allografting effectively modulates cardiac rejection. |
1996 |
Transplant. Proc. |
pmid:8658660
|
Ohtsuka S et al. |
The effect of short-term FK 506 therapy on pancreas transplantation in rats. |
1991 |
Transplant. Proc. |
pmid:1721413
|
Tanabe K et al. |
Diabetes mellitus after renal transplantation under FK 506 (tacrolimus) as primary immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8658670
|
Cirocco RE et al. |
Kidney recipient CMV incidence in the gancyclovir era: monitoring viral DNA by a CMV-PCR assay. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083604
|
Nakao A et al. |
Cytokine mRNA expression on rat small bowel allograft treated with tacrolimus and simultaneous bone marrow transplantation via the portal vein. |
2000 |
Transplant. Proc. |
pmid:10995965
|
Soltero L et al. |
Coadministration of tacrolimus and ketoconazole in renal transplant recipients: cost analysis and review of metabolic effects. |
2003 |
Transplant. Proc. |
pmid:12826147
|
Levy GA |
Neoral is superior to FK 506 in liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9723293
|
Glanemann M et al. |
Higher immunosuppressive efficacy of mycophenolate mofetil in combination with FK 506 than in combination with cyclosporine A. |
2000 |
Transplant. Proc. |
pmid:10812095
|
Fábrega E et al. |
Effect of immunosuppressant blood levels on serum concentration of interleukin-17 and -23 in stable liver transplant recipients. |
2009 |
Transplant. Proc. |
pmid:19376417
|
Burke GW et al. |
Steroid-resistant acute rejection following SPK: importance of maintaining therapeutic dosing in a triple-drug regimen. |
2002 |
Transplant. Proc. |
pmid:12176628
|
El-Safa EA et al. |
Paradoxical response to tacrolimus assessed by interleukin-2 gene expression. |
2006 |
Transplant. Proc. |
pmid:17175263
|
Moura Neto A et al. |
Frequency of Thyroid Dysfunction in Patients With Diabetes Mellitus Before and After Liver Transplantation. |
2018 |
Transplant. Proc. |
pmid:29661439
|
Sperschneider H |
A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267291
|
Wada H et al. |
Dose response to FK 506 in canine lung transplantation. |
1991 |
Transplant. Proc. |
pmid:1721444
|
Shapiro R |
Tacrolimus in solid organ transplantation: an update. |
1999 |
Transplant. Proc. |
pmid:10500545
|
McMaster P and Buist L |
FK 506 in transplantation. |
1993 |
Transplant. Proc. |
pmid:7689275
|
Martins L et al. |
Conversion to tacrolimus in case-problem kidney transplant recipients under cyclosporine-based immunosuppression. |
2000 |
Transplant. Proc. |
pmid:11134735
|
Hanack U et al. |
Is there a different impact of cyclosporine versus tacrolimus on delayed graft function after kidney transplantation? |
1998 |
Transplant. Proc. |
pmid:9723477
|
Chamienia A et al. |
Open prospective study to evaluate cardiovascular risk factors and renal function in 2 dosage regimens of tacrolimus combined with mycophenolate mofetil and steroids in renal transplant patients: 5-year results. |
2014 |
Transplant. Proc. |
pmid:25380901
|
Mohsin N et al. |
Low tacrolimus dose requirements in renal transplant recipients in the omani population: implications for pharmacogenetics? |
2005 |
Transplant. Proc. |
pmid:16213259
|
Kocak H et al. |
Tacrolimus plus low-dose mycophenolate mofetil in renal transplant recipients: better 2-year graft and patient survival than with a higher mycophenolate mofetil dose. |
2005 |
Transplant. Proc. |
pmid:16213288
|
Lee CM et al. |
Monotherapy with tacrolimus for heart and liver transplant: a case report. |
2014 |
Transplant. Proc. |
pmid:24767396
|
Reimer J et al. |
Quality of life after kidney transplantation--the impact of tacrolimus. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267573
|
McLaughlin GE et al. |
Effect of aminophylline on urine flow in children with tacrolimus-induced renal insufficiency. |
2000 |
Transplant. Proc. |
pmid:10856596
|
Fritsche L et al. |
Conversion to mycophenolate mofetil for chronic progressive deterioration of renal allograft function: first clinical experiences in 44 patients. |
1998 |
Transplant. Proc. |
pmid:9636481
|
Matsumoto S et al. |
ET-Kyoto ductal injection and density-adjusted purification combined with potent anti-inflammatory strategy facilitated single-donor islet transplantation: case reports. |
2010 Jul-Aug |
Transplant. Proc. |
pmid:20692433
|